Seung Min Kim

Seung Min Kim

Auto-generated profile, based on publicly available information

Seung Min Kim

Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in Brain
Verified
Journal Article
Open access
PDF file
KCK. W. Chung
K. W. Chung
SKS. B. Kim
S. B. Kim
KPK. D. Park
K. D. Park
KCK. G. Choi
K. G. Choi
JLJ. H. Lee
J. H. Lee
BCB. O. Choi
B. O. Choi
Mutations in the mitofusin 2 (MFN2) gene, which encodes a mitochondrial GTPase mitofusin protein, have recently been reported to cause both Charcot–Marie–Tooth 2A (CMT2A) and hereditary motor and sensory neuropathy VI (HMSN VI). It is well known that HMSN VI is an axonal CMT neuropathy with optic atrophy. However, the differences between CMT2A and HMSN VI with MFN2 mutations remained to be clarified. Therefore, we studied the phenotypic characteristics of CMT patients with MFN2 mutations. Mutations in MFN2 were screened in 62 unrelated axonal CMT neuropathy families. We calculated CMT neuropathy scores (CMTNSs) and functional disability scales (FDSs) to quantify disease severity. Twenty-one patients with the MFN2 mutations were studied by brain MRI. Ten pathogenic mutations were identified in 26 patients from 15 families (24.2%). Six of these mutations had not been reported, and de novo mutations were observed in five families (33.3%). The electrophysiological patterns of affected individuals with the MFN2 mutations were typical of axonal CMT; however, the clinical and electrophysiological characteristics were markedly different in early (<10 years) and late disease-onset (≥10 years) groups. All patients with an early onset had severe CMTNS (≥21) and FDS (6 or 7), whereas most patients with late onset had mild CMTNS (≤10) and FDS (≤3). We identified two HMSN VI families with the R364W mutation in the early onset group; however, two other families with the same mutation did not have optic atrophy. In addition, two early onset families with R94W mutations, previously reported for HMSN VI, did not have visual impairment. Interestingly, eight patients had periventricular and subcortical hyperintense lesions by brain MRI. In the late-onset group, three patients had sensorineural hearing loss and two had bilateral extensor plantar responses. We found that MFN2 mutations are the major cause of axonal CMT neuropathy, and that they are associated with variable CNS involvements. Phenotypes were significantly different in the early and late disease-onset groups. Our findings suggest that HMSN VI might be a variant of the early onset severe CMT2A phenotype.

1 August 2008 in Neuromuscular Disorders
Verified
Journal Article
Closed access
KCK.W. Chung
K.W. Chung
BSB.C. Suh
B.C. Suh
MSMichael Shy
Michael Shy
SCS.Y. Cho
S.Y. Cho
JYJ.H. Yoo
J.H. Yoo
BCB.O. Choi
B.O. Choi


15 April 2009 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
HPH. J. Park
H. J. Park
HCH. J. Cho
H. J. Cho
YKYoung Dae Kim
Young Dae Kim
DLD. W. Lee
D. W. Lee
HCH.‐Y. Choi
H.‐Y. Choi
JHJi Hoe Heo
Ji Hoe Heo
Background and purpose:  Patients who are being admitted to a hospital due to diseases other than stroke may develop a stroke (in‐hospital stroke; IHS).Methods:  We enrolled 111 consecutive patients who developed IHS outside a neurology ward during a 5‐year period at a single hospital. The frequency, characteristics, and outcomes for IHS patients were compared with patients who develop ischaemic stroke outside of the hospital (out‐of‐hospital stroke; OHS).Results:  Forty‐six percent of IHS occurred in the department of cardiology or cardiovascular surgery and 60% were associated with surgery or procedures. In comparison with the OHS patient group, the IHS patient group showed an increased frequency of cardiac disease, leukocytosis, and anemia. Cardioembolism, stroke of other determined etiologies, and an incomplete evaluation were more common in the IHS group, whereas large artery atherosclerosis was more frequent in the OHS group. The IHS group had up to a 10‐fold higher mortality than the OHS group, with sepsis being the most common cause of death in the IHS group.Conclusions:  IHS has distinct etiologies and stroke mechanisms from OHS. The prevention and management of infection could decrease mortality in IHS patients.

1 January 2012 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
KKKyoungsub Kim
Kyoungsub Kim
HLHye Sun Lee
Hye Sun Lee
YJYo Han Jung
Yo Han Jung
YKYoung Dae Kim
Young Dae Kim
HYO SUK NAMHYO SUK NAM
HYO SUK NAM
JHJi Hoe Heo
Ji Hoe Heo
Kim K, et al. J Clin Neurol. 2012 Jun;8(2):116-122. http://dx.doi.org/10.3988/jcn.2012.8.2.116

31 January 2008 in Journal of Human Genetics
Verified
Journal Article
Closed access
KCKi Wha Chung
Ki Wha Chung
SKSeung Min Kim
Seung Min Kim
ISIl Nam Sunwoo
Il Nam Sunwoo
SCSun Young Cho
Sun Young Cho
SHSu Jin Hwang
Su Jin Hwang
BCByung-Ok Choi
Byung-Ok Choi